Brazil · Delayed Price · Currency is BRL Ascendis Pharma Statistics
Total Valuation
Ascendis Pharma has a market cap or net worth of BRL 64.46 billion. The enterprise value is 66.17 billion.
| Market Cap | 64.46B |
| Enterprise Value | 66.17B |
Important Dates
The last earnings date was Tuesday, November 4, 2025.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.73% |
| Shares Change (QoQ) | +6.49% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 60.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 71.01 |
| PS Ratio | 15.94 |
| PB Ratio | -59.22 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -45.43 |
| EV / Sales | 16.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -94.35 |
Financial Position
The company has a current ratio of 1.03
| Current Ratio | 1.03 |
| Quick Ratio | 0.70 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -7.25 |
| Interest Coverage | -1.04 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -8.10% |
| Return on Invested Capital (ROIC) | -13.69% |
| Return on Capital Employed (ROCE) | -86.64% |
| Revenue Per Employee | 3.98M |
| Profits Per Employee | -1.43M |
| Employee Count | 1,017 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 0.30 |
Taxes
In the past 12 months, Ascendis Pharma has paid 60.10 million in taxes.
| Income Tax | 60.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +45.06% in the last 52 weeks. The beta is 0.45, so Ascendis Pharma's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +45.06% |
| 50-Day Moving Average | 62.73 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 55.70 |
| Average Volume (20 Days) | 235 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ascendis Pharma had revenue of BRL 4.04 billion and -1.46 billion in losses. Loss per share was -24.18.
| Revenue | 4.04B |
| Gross Profit | 3.51B |
| Operating Income | -911.58M |
| Pretax Income | -1.40B |
| Net Income | -1.46B |
| EBITDA | -883.02M |
| EBIT | -911.58M |
| Loss Per Share | -24.18 |
Balance Sheet
The company has 3.37 billion in cash and 5.09 billion in debt, giving a net cash position of -1.72 billion.
| Cash & Cash Equivalents | 3.37B |
| Total Debt | 5.09B |
| Net Cash | -1.72B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -1.09B |
| Book Value Per Share | -17.85 |
| Working Capital | 195.70M |
Cash Flow
In the last 12 months, operating cash flow was -667.05 million and capital expenditures -34.25 million, giving a free cash flow of -701.29 million.
| Operating Cash Flow | -667.05M |
| Capital Expenditures | -34.25M |
| Free Cash Flow | -701.29M |
| FCF Per Share | n/a |
Margins
Gross margin is 86.80%, with operating and profit margins of -22.55% and -36.03%.
| Gross Margin | 86.80% |
| Operating Margin | -22.55% |
| Pretax Margin | -34.54% |
| Profit Margin | -36.03% |
| EBITDA Margin | -21.84% |
| EBIT Margin | -22.55% |
| FCF Margin | n/a |
Dividends & Yields
Ascendis Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.73% |
| Shareholder Yield | -4.73% |
| Earnings Yield | -2.26% |
| FCF Yield | -1.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |